AUVI-Q® (epinephrine injection, USP) is only approved for sale in the U.S. AUVI-Q is designed to be easy to use and to carry for whoever may be called upon to use it with innovative features like voice instructions, an auto-retractable needle and a pocket-sized design. AUVI-Q is available in 3 dosages • 0.1 mg – the first and only FDA approved epinephrine auto-injector for infants and toddlers weighing 16.5-33 lbs • 0.15 mg – for children weighing 33 to 66 lbs • 0.3 mg – for anyone weighing 66 lbs or more E-prescribing AUVI-Q is easy – in your EMR select ASPN for home delivery or send the prescription to your patient’s preferred Walgreens location. See detailed prescribing instructions at https://www.auviq.com/hcp/prescribing. Patients should seek emergency medical care after using AUVI-Q. To minimize the risk of injection-related injury, instruct caregivers to hold a young child’s or infant’s leg firmly in place when administering AUVI-Q. Visit auvi- q.com/important-safety-information to see the full AUVI-Q Indication and Important Safety Information.